Home NDC 0173-0861 AVANDIA
Product NDC 0173-0861
11-digit product format 001730861
Labeler code 0173
Product ID 0173-0861_4b7ec529-e57b-4115-b561-235bee3790dc
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name rosiglitazone maleate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler GlaxoSmithKline LLC
Application NDA021071
Marketing category NDA
Marketing start 2011-05-25
Marketing end 2021-09-30
Substance ROSIGLITAZONE MALEATE
Active strength 2 mg/1
Pharmacologic classes Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0173-0861-18 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0173-0861-18 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0173-0861-18 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0173-0861-18 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0173-0861-18 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0173-0861-18 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0173-0861-18 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0173-0861-18 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0173-0861-18 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0173-0861-18 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0173-0861-18 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0173-0861-18 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021071-002 AVANDIA ROSIGLITAZONE MALEATE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 N021071-003 AVANDIA ROSIGLITAZONE MALEATE EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 N021071-004 AVANDIA ROSIGLITAZONE MALEATE EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021071-002 AVANDIA EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021071-003 AVANDIA EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021071-002 AVANDIA EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021071-003 AVANDIA EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021071-002 AVANDIA EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021071-003 AVANDIA EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021071-002 AVANDIA EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021071-003 AVANDIA EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021071-002 AVANDIA EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021071-003 AVANDIA EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021071-003 AVANDIA EQ 4MG BASE TABLET / ORAL RLD 1999-05-25 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021071-004 AVANDIA EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1999-05-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021071-002 AVANDIA EQ 2MG BASE TABLET / ORAL RLD 1999-05-25 301d65b070ca…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021071-002 7358366 2020-04-19 Drug substance, Delist requested 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021071-002 7358366*PED 2020-10-19 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021071-003 7358366 2020-04-19 Drug substance, Delist requested 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021071-003 7358366*PED 2020-10-19 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021071-004 7358366 2020-04-19 Drug substance, Delist requested 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021071-004 7358366*PED 2020-10-19 Pediatric extension 74a2ff9319b5…2020-12-22 03:56 UTC 2020-12 N021071-002 7358366 2020-04-19 Drug substance, Delist requested 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021071-002 7358366*PED 2020-10-19 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021071-003 7358366 2020-04-19 Drug substance, Delist requested 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021071-003 7358366*PED 2020-10-19 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021071-004 7358366 2020-04-19 Drug substance, Delist requested 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021071-004 7358366*PED 2020-10-19 Pediatric extension 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021071-002 7358366 2020-04-19 Drug substance, Delist requested c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021071-002 7358366*PED 2020-10-19 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021071-003 7358366 2020-04-19 Drug substance, Delist requested c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021071-003 7358366*PED 2020-10-19 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021071-004 7358366 2020-04-19 Drug substance, Delist requested c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021071-004 7358366*PED 2020-10-19 Pediatric extension c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021071-002 7358366 2020-04-19 Drug substance, Delist requested 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021071-002 7358366*PED 2020-10-19 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021071-003 7358366 2020-04-19 Drug substance, Delist requested 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021071-003 7358366*PED 2020-10-19 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021071-004 7358366 2020-04-19 Drug substance, Delist requested 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021071-004 7358366*PED 2020-10-19 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021071-002 7358366 2020-04-19 Drug substance, Delist requested b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021071-002 7358366*PED 2020-10-19 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021071-003 7358366 2020-04-19 Drug substance, Delist requested b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021071-003 7358366*PED 2020-10-19 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021071-004 7358366 2020-04-19 Drug substance, Delist requested b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021071-004 7358366*PED 2020-10-19 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021071-002 7358366 2020-04-19 Drug substance, Delist requested ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021071-002 7358366*PED 2020-10-19 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021071-003 7358366 2020-04-19 Drug substance, Delist requested ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021071-003 7358366*PED 2020-10-19 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021071-004 7358366 2020-04-19 Drug substance, Delist requested ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021071-004 7358366*PED 2020-10-19 Pediatric extension ea99ee380514…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ROSIGLITAZONE MALEATE ACTIVE INGREDIENT KX2339DP44 AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 ROSIGLITAZONE ACTIVE MOIETY 05V02F2KDG AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 HYPROMELLOSE 2910 (3 MPA.S) INACTIVE INGREDIENT 0VUT3PMY82 AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 POLYETHYLENE GLYCOL 3000 INACTIVE INGREDIENT SA1B764746 AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 TALC INACTIVE INGREDIENT 7SEV7J4R1U AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 AVANDIA (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 2MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 4MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED AVANDIA 8MG (ROSIGLITAZONE MALEATE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] 8
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0173-0861-18 00173086118 60 TABLET, FILM COATED in 1 BOTTLE (0173-0861-18) 2011-05-25 2021-09-30 No No Current